Review
World J Pharmacol
3(4):39-55.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.39
Abstract (1901)
|
Core Tip (1653)
|
Full Article (HTML) (15311)
|
Figures (1-3) (388)
|
Tables (1-5) (416)
|
Full Article (PDF)-1451K (1240)
|
Peer-Review Report-94K (379)
|
Answering Reviewers-72K (300)
|
Received: 06/26/2014
|
Revised: 09/09/2014
|
Accepted: 10/10/2014
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (60)
|
Total Visits (28157)
|
Similar Articles (6)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Pharmacol
3(4):56-71.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.56
Abstract (1918)
|
Core Tip (1562)
|
Full Article (HTML) (8880)
|
Figures (1-1) (726)
|
Tables (1-3) (350)
|
Full Article (PDF)-1210K (730)
|
Peer-Review Report-98K (320)
|
Answering Reviewers-99K (267)
|
Received: 07/01/2014
|
Revised: 08/01/2014
|
Accepted: 09/17/2014
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (18305)
|
Similar Articles (162)
|
Timeline of Article Publication (5)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Pharmacol
3(4):72-85.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.72
Abstract (1729)
|
Core Tip (1577)
|
Full Article (HTML) (9534)
|
Figures (1-4) (1160)
|
Tables (1-1) (360)
|
Full Article (PDF)-1374K (1060)
|
Peer-Review Report-105K (309)
|
Answering Reviewers-58K (392)
|
Received: 07/28/2014
|
Revised: 08/29/2014
|
Accepted: 09/24/2014
|
CrossRef
|
Google Scholar
|
Times Cited (8)
|
Total Visits (19804)
|
Similar Articles (7)
|
Timeline of Article Publication (3)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Pharmacol
3(4):86-96.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.86
Abstract (1585)
|
Core Tip (1552)
|
Full Article (HTML) (7187)
|
Figures (1-3) (480)
|
Full Article (PDF)-2317K (797)
|
Peer-Review Report-102K (310)
|
Answering Reviewers-250K (370)
|
Received: 07/28/2014
|
Revised: 10/01/2014
|
Accepted: 10/29/2014
|
CrossRef
|
Google Scholar
|
Times Cited (5)
|
Total Visits (15481)
|
Similar Articles (2)
|
Timeline of Article Publication (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Pharmacol
3(4):97-109.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.97
Abstract (1368)
|
Core Tip (1250)
|
Full Article (HTML) (5752)
|
Figures (1-1) (348)
|
Tables (1-4) (358)
|
Full Article (PDF)-1455K (690)
|
Peer-Review Report-129K (191)
|
Answering Reviewers-81K (212)
|
Received: 06/28/2014
|
Revised: 10/02/2014
|
Accepted: 11/10/2014
|
CrossRef
|
Google Scholar
|
Times Cited (3)
|
Total Visits (13071)
|
Similar Articles (0)
|
Timeline of Article Publication (2)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Harnessing pharmacological knowledge for personalized medicine and pharmacotyping: Challenges and lessons learned

World J Pharmacol
3(4):110-119.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.110
Abstract (1405)
|
Core Tip (1181)
|
Full Article (HTML) (3928)
|
Figures (1-1) (374)
|
Tables (1-1) (333)
|
Full Article (PDF)-2534K (524)
|
Peer-Review Report-98K (252)
|
Answering Reviewers-19K (182)
|
Received: 06/12/2014
|
Revised: 07/03/2014
|
Accepted: 10/29/2014
|
CrossRef
|
Google Scholar
|
Times Cited (2)
|
Total Visits (11923)
|
Similar Articles (7)
|
Timeline of Article Publication (6)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Pharmacol
3(4):120-139.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.120
Abstract (1756)
|
Core Tip (1387)
|
Full Article (HTML) (8417)
|
Figures (1-2) (459)
|
Tables (1-1) (289)
|
Full Article (PDF)-1376K (738)
|
Peer-Review Report-116K (412)
|
Answering Reviewers-78K (335)
|
Received: 06/29/2014
|
Revised: 09/01/2014
|
Accepted: 09/24/2014
|
CrossRef
|
Google Scholar
|
Times Cited (3)
|
Total Visits (19831)
|
Similar Articles (67)
|
Timeline of Article Publication (2)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Pharmacol
3(4):140-152.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.140
Abstract (1726)
|
Core Tip (1578)
|
Full Article (HTML) (7854)
|
Figures (1-2) (338)
|
Tables (1-1) (310)
|
Full Article (PDF)-2415K (513)
|
Peer-Review Report-106K (384)
|
Answering Reviewers-72K (286)
|
Received: 06/27/2014
|
Revised: 10/02/2014
|
Accepted: 11/03/2014
|
CrossRef
|
Google Scholar
|
Times Cited (15)
|
Total Visits (16042)
|
Similar Articles (0)
|
Timeline of Article Publication (2)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(1)
|
Open
Minireviews
Pharmacological role of efflux transporters: Clinical implications for medication use during breastfeeding

World J Pharmacol
3(4):153-161.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.153
Abstract (1577)
|
Core Tip (1451)
|
Full Article (HTML) (5530)
|
Figures (1-1) (334)
|
Full Article (PDF)-1040K (573)
|
Peer-Review Report-104K (335)
|
Answering Reviewers-60K (248)
|
Received: 06/28/2014
|
Revised: 09/03/2014
|
Accepted: 09/24/2014
|
CrossRef
|
Google Scholar
|
Times Cited (6)
|
Total Visits (13429)
|
Similar Articles (10)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Pharmacol
3(4):162-173.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.162
Abstract (1610)
|
Core Tip (1653)
|
Full Article (HTML) (7077)
|
Figures (1-2) (384)
|
Tables (1-1) (322)
|
Full Article (PDF)-4747K (795)
|
Peer-Review Report-116K (343)
|
Answering Reviewers-128K (330)
|
Received: 06/27/2014
|
Revised: 08/07/2014
|
Accepted: 10/29/2014
|
CrossRef
|
Google Scholar
|
Times Cited (6)
|
Total Visits (18647)
|
Similar Articles (2)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Pharmacol
3(4):174-185.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.174
Abstract (1309)
|
Core Tip (1091)
|
Full Article (HTML) (4485)
|
Tables (1-1) (361)
|
Full Article (PDF)-1054K (409)
|
Peer-Review Report-106K (288)
|
Answering Reviewers-75K (204)
|
Received: 07/29/2014
|
Revised: 10/02/2014
|
Accepted: 10/27/2014
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (11153)
|
Similar Articles (18)
|
Timeline of Article Publication (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Pharmacol
3(4):186-192.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.186
Abstract (1534)
|
Core Tip (1184)
|
Full Article (HTML) (6857)
|
Tables (1-2) (348)
|
Full Article (PDF)-872K (655)
|
Peer-Review Report-82K (312)
|
Answering Reviewers-100K (269)
|
Received: 05/16/2014
|
Revised: 07/04/2014
|
Accepted: 09/17/2014
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (15506)
|
Similar Articles (29)
|
Timeline of Article Publication (2)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Therapeutics Advances
World J Pharmacol
3(4):193-198.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.193
Abstract (1351)
|
Core Tip (1088)
|
Full Article (HTML) (2513)
|
Figures (1-2) (287)
|
Tables (1-1) (303)
|
Full Article (PDF)-1053K (362)
|
Peer-Review Report-98K (324)
|
Answering Reviewers-31K (182)
|
Received: 06/24/2014
|
Revised: 09/22/2014
|
Accepted: 10/10/2014
|
CrossRef
|
Google Scholar
|
Times Cited (3)
|
Total Visits (12125)
|
Similar Articles (751)
|
Timeline of Article Publication (2)
|
Authors Evaluation (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Evidence-Based Medicine
World J Pharmacol
3(4):199-208.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.199
Abstract (1534)
|
Core Tip (1368)
|
Full Article (HTML) (6983)
|
Tables (1-4) (438)
|
Full Article (PDF)-1067K (591)
|
Peer-Review Report-118K (297)
|
Answering Reviewers-113K (317)
|
Received: 07/28/2014
|
Revised: 09/08/2014
|
Accepted: 10/16/2014
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (15182)
|
Similar Articles (75)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Systematic Reviews
Association of serum bilirubin and non-alcoholic fatty liver disease: A feasible therapeutic avenue?

World J Pharmacol
3(4):209-216.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.209
Abstract (1584)
|
Core Tip (1266)
|
Full Article (HTML) (9056)
|
Figures (1-1) (324)
|
Tables (1-2) (522)
|
Full Article (PDF)-1014K (471)
|
Peer-Review Report-80K (291)
|
Answering Reviewers-67K (225)
|
Received: 05/21/2014
|
Revised: 07/14/2014
|
Accepted: 10/27/2014
|
CrossRef
|
Google Scholar
|
Times Cited (2)
|
Total Visits (17567)
|
Similar Articles (222)
|
Timeline of Article Publication (5)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open